Zhang Wencheng について
Department of Radiation Oncology, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China について
Pang Qingsong について
Department of Radiation Oncology, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China について
Zhang Xiaodong について
Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA について
Yan Cihui について
Departments of Immunology, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China について
Wang Qifeng について
Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Beijing, China について
Yang Jinsong について
Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Beijing, China について
Yu Shufei について
Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Beijing, China について
Liu Xiao について
Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Beijing, China について
Department of Pathology, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China について
Yuan Zhiyong について
Department of Radiation Oncology, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China について
Wang Ping について
Department of Radiation Oncology, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China について
Xiao Zefen について
Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Beijing, China について
Cancer Science (Web) について
CD抗原 について
PD-L1 について
抄録等の続きを表示するにはログインが必要です。なお医療系文献の抄録につきましてはアカウント情報にて「医療系文献の抄録等表示の希望」を設定する必要があります。
Epidermal growth factor receptor について
esophageal squamous cell carcinoma について
programmed death-ligand 1 について
radiation について
tumor-infiltrating immune cell について
腫ようの放射線療法 について
抗腫よう薬の臨床への応用 について
腫よう免疫 について
食道扁平上皮癌 について
予後因子 について
上皮増殖因子受容体 について